John E. Shively
27Patents
7h-index
31Co-inventors
69Inventor score
Filing activity: Apr 18, 1985 → Oct 15, 2021
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5081235A | Chimeric anti-CEA antibody | Chemistry; Metallurgy | 19 | Expired |
| US4873313A | Specific hybridoma cell line and monocolonal antibodies produced from such specific hybridoma cell line and method of using such monoclonal antibodies to detect carcinoembryonic antigens | Emerging Cross-Sectional Technologies | 18 | Expired |
| US5137695A | Apparatus for the sequential performance of chemical processes | Chemistry; Metallurgy | 14 | Expired |
| US7776330B2 | Humanized anti-CEA T84.66 antibody and uses thereof | Chemistry; Metallurgy | 13 | Active |
| US5432092A | C-terminal peptide sequencing using diphenyl phosphoroisothiocyanatidate and pyridine | Chemistry; Metallurgy | 11 | Expired |
| US5075431A | Chimeric anti-CEA antibody | Chemistry; Metallurgy | 10 | Expired |
| US5861125A | Protein or peptide sequencing method and apparatus | Emerging Cross-Sectional Technologies | 7 | Expired |
| US5180807A | C-terminal peptide or protein sequencing reagent and method | Physics | 6 | Expired |
| US5061635A | Protein or peptide sequencing method | Emerging Cross-Sectional Technologies | 3 | Expired |
| US9701754B1 | Covalent disulfide-linked diabodies and uses thereof | Chemistry; Metallurgy | 3 | Active |
| US9765155B2 | Covalent disulfide-linked diabodies and uses thereof | Chemistry; Metallurgy | 3 | Active |
| US7273608B2 | Humanized anti-CEA T84.66 antibody and uses thereof | Chemistry; Metallurgy | 3 | Expired |
| US5432093A | Sequential degradation of proteins and peptides from the N-terminus | Emerging Cross-Sectional Technologies | 3 | Expired |
| US10967070B2 | Cell penetrating conjugates and methods of use thereof | Chemistry; Metallurgy | 2 | Active |
| US5432091A | N-terminal sequencing of proteins and peptides | Physics | 2 | Expired |
| US5227309A | C-terminal peptide sequencing method | Emerging Cross-Sectional Technologies | 1 | Expired |
| US10603328B2 | Methods of treating advanced prostate cancer | Human Necessities | 1 | Active |
| US8513013B2 | Generation of novel bone forming cells (monoosteophils) from LL-37 treated monocytes | Chemistry; Metallurgy | 0 | Active |
| US7541196B2 | Planar optical waveguide based sandwich assay sensors and processes for the detection of biological targets including early detection of cancers | Emerging Cross-Sectional Technologies | 0 | Expired |
| US10471161B2 | Vinylsulfone-based 18F-labeling compositions and methods and uses thereof | Chemistry; Metallurgy | 0 | Active |
| US5541114A | Sequencing of protein immobilized on polytetrafluoroethylene supports | Physics | 0 | Expired |
| US11541062B2 | Methods of treating advanced prostate cancer | Human Necessities | 0 | Active |
| US12043673B2 | Complementary RNA linked bispecific T-cell engaging antibodies | Chemistry; Metallurgy | 0 | Active |
| US5986071A | Method for C-terminal degradation of peptides and proteins | Physics | 0 | Expired |
| US5525707A | N-terminal peptide degradation utilizing dialkylthiocarbamoylhalides | Chemistry; Metallurgy | 0 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.